201 related articles for article (PubMed ID: 32174022)
21. Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α
Hou SM; Hsia CW; Tsai CL; Hsia CH; Jayakumar T; Velusamy M; Sheu JR
J Biomed Sci; 2020 May; 27(1):60. PubMed ID: 32375785
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of hydrogen on in vitro platelet activation and in vivo prevention of thrombosis formation.
Wang Y; Wu YP; Han JJ; Zhang MQ; Yang CX; Jiao P; Tian H; Zhu C; Qin SC; Sun XJ; Zhang HT; Zhao XM
Life Sci; 2019 Sep; 233():116700. PubMed ID: 31356907
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
Mosawy S; Jackson DE; Woodman OL; Linden MD
Platelets; 2013; 24(8):594-604. PubMed ID: 23249183
[TBL] [Abstract][Full Text] [Related]
24. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y
Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483
[TBL] [Abstract][Full Text] [Related]
25. Fatty acid oxidation fuels agonist-induced platelet activation and thrombus formation: Targeting β-oxidation of fatty acids as an effective anti-platelet strategy.
Kulkarni PP; Ekhlak M; Singh V; Kailashiya V; Singh N; Dash D
FASEB J; 2023 Feb; 37(2):e22768. PubMed ID: 36624703
[TBL] [Abstract][Full Text] [Related]
26. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis.
Zhou Q; Jiang L; Xu C; Luo D; Zeng C; Liu P; Yue M; Liu Y; Hu X; Hu H
Thromb Res; 2014 Jan; 133(1):57-65. PubMed ID: 24196231
[TBL] [Abstract][Full Text] [Related]
27. Impaired Platelet Function and Thrombus Formation in PDE5A-Deficient Mice.
Gui X; Chu X; Du Y; Wang Y; Zhang S; Ding Y; Tong H; Xu M; Li Y; Ju W; Sun Z; Li Z; Zeng L; Xu K; Qiao J
Thromb Haemost; 2023 Feb; 123(2):207-218. PubMed ID: 36252813
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis.
Duan X; Perveen R; Dandamudi A; Adili R; Johnson J; Funk K; Berryman M; Davis AK; Holinstat M; Zheng Y; Akbar H
Sci Rep; 2021 Jun; 11(1):13170. PubMed ID: 34162972
[TBL] [Abstract][Full Text] [Related]
29. Loss of Reelin protects mice against arterial thrombosis by impairing integrin activation and thrombus formation under high shear conditions.
Gowert NS; Krüger I; Klier M; Donner L; Kipkeew F; Gliem M; Bradshaw NJ; Lutz D; Köber S; Langer H; Jander S; Jurk K; Frotscher M; Korth C; Bock HH; Elvers M
Cell Signal; 2017 Dec; 40():210-221. PubMed ID: 28943410
[TBL] [Abstract][Full Text] [Related]
30. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
31. Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate.
Hsia CW; Wu MP; Velusamy M; Hsia CH; Chou DS; Tsai CL; Hsu CY; Jayakumar T; Chung CL; Sheu JR
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104547
[TBL] [Abstract][Full Text] [Related]
32. A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
Hsia CH; Velusamy M; Sheu JR; Khamrang T; Jayakumar T; Lu WJ; Lin KH; Chang CC
Sci Rep; 2017 Aug; 7(1):9556. PubMed ID: 28842683
[TBL] [Abstract][Full Text] [Related]
33. The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation.
Ampofo E; Später T; Nalbach L; Menger MD; Laschke MW
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32074969
[TBL] [Abstract][Full Text] [Related]
34. The role of platelet and endothelial GARP in thrombosis and hemostasis.
Vermeersch E; Denorme F; Maes W; De Meyer SF; Vanhoorelbeke K; Edwards J; Shevach EM; Unutmaz D; Fujii H; Deckmyn H; Tersteeg C
PLoS One; 2017; 12(3):e0173329. PubMed ID: 28278197
[TBL] [Abstract][Full Text] [Related]
35. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
Zhang Y; Zhang J; Yan R; Tian J; Zhang Y; Zhang J; Chen M; Cui Q; Zhao L; Hu R; Jiang M; Li Z; Ruan C; He S; Dai K
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2964-2969. PubMed ID: 28242694
[TBL] [Abstract][Full Text] [Related]
36. Atractylodes lactone compounds inhibit platelet activation.
Chen Y; Yang W; Guo L; Wu X; Zhang T; Liu J; Zhang J
Platelets; 2017 Mar; 28(2):194-202. PubMed ID: 27560602
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
[TBL] [Abstract][Full Text] [Related]
38. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
[TBL] [Abstract][Full Text] [Related]
39. 1,8-Cineole Affects Agonists-Induced Platelet Activation, Thrombus Formation and Haemostasis.
Alatawi KA; Ravishankar D; Patra PH; Bye AP; Stainer AR; Patel K; Widera D; Vaiyapuri S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685597
[TBL] [Abstract][Full Text] [Related]
40. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
